Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 2

Status

Completed 36Recruiting 24Terminated 15Active not recruiting 14Unknown 6Not yet recruiting 6Withdrawn 2Suspended 2

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 6

Conditions

Breast Neoplasms 1275Carcinoma, Non-Small-Cell Lung 783Neoplasms 767Colorectal Neoplasms 755Carcinoma, Hepatocellular 579Stomach Neoplasms 578Prostatic Neoplasms 501Lung Neoplasms 461Pancreatic Neoplasms 416Rectal Neoplasms 331Recurrence 312Neoplasm Metastasis 305Leukemia, Myeloid, Acute 289Multiple Myeloma 281Colonic Neoplasms 280Lymphoma 273Uterine Cervical Neoplasms 269Esophageal Neoplasms 267Ovarian Neoplasms 261Head and Neck Neoplasms 246Melanoma 240Precursor Cell Lymphoblastic Leukemia-Lymphoma 209Brain Neoplasms 195Lymphoma, Large B-Cell, Diffuse 184Nasopharyngeal Carcinoma 180Lymphoma, Non-Hodgkin 173Leukemia 173Liver Neoplasms 163Glioblastoma 158Urinary Bladder Neoplasms 153

Interventions

Temozolomide 2nimotuzumab 1Vinorelbine 1Valproic Acid 1Radiotherapy 1Everolimus 1Erlotinib Hydrochloride 1Drug Therapy 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Interventional × Diffuse Intrinsic Pontine Glioma × Clear all
NCT03620032 2023-12-06

DIPG

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
54 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

NCT04532229 2023-07-27

Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children

Biotech Pharmaceutical Co., Ltd.

Phase 3 Unknown
48 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

NCT03243461 2022-06-06

HIT-HGG-2013

University of Göttingen

Phase 3 Unknown
167 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neuroepithelial

NCT03914768 2020-06-12

Immune Modulatory DC Vaccine Against Brain Tumor

Shenzhen Geno-Immune Medical Institute

Phase 1 Unknown
10 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioblastoma

NCT02233049 2018-07-23

BIOMEDE

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown
250 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

NCT02840123 2018-03-02

Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines

Fundació Sant Joan de Déu

Phase 1 Unknown
10 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡